financetom
Business
financetom
/
Business
/
Ball Corp's second-quarter profit beats as cost savings pay off
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ball Corp's second-quarter profit beats as cost savings pay off
Aug 1, 2024 4:46 AM

(Reuters) - Ball Corp ( BALL ) reported a second-quarter profit on Thursday that beat analysts' estimates as the beer can maker benefited from cost-reduction plans and lower input costs.

The company, whose customers include Corona beer maker Constellation Brands, has been streamlining its business and cutting down on higher cost facilities.

In February, Ball Corp ( BALL ) completed the sale of its aerospace business to focus on aluminum packaging - demand for which has been growing as companies look for more sustainable alternatives to plastic.

Still, muted consumer spending on food and beverages in North America and Europe due to sticky inflation has prompted consumer goods companies to temper inventories, denting demand.

The Colorado-based company reported sales of $1.47 billion at its beverage packaging business in North and Central America, missing estimates of $1.52 billion, according to LSEG data.

Volumes at its beverage packaging segment were also lower in South America, hurt by "disruptive economic and operating conditions in Argentina," according to the company.

Ball Corp ( BALL ) forecast annual adjusted profit to grow by a mid-single-digit plus percentage. Analysts had expected full-year earnings to increase 5.4%.

On an adjusted basis, the company earned 74 per share, beating estimates of 70 cents.

Ball Corp's ( BALL ) net sales for the quarter ending June 30 fell 3.5% to $2.96 billion, missing estimates of $3.10 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vir Biotechnology Completes Enrollment in Phase 2 Chronic Hepatitis Delta Trial Ahead of Schedule
Vir Biotechnology Completes Enrollment in Phase 2 Chronic Hepatitis Delta Trial Ahead of Schedule
Mar 5, 2024
12:05 PM EST, 03/05/2024 (MT Newswires) -- Vir Biotechnology ( VIR ) said Tuesday it completed enrollment of its current groups in a phase 2 clinical trial of tobevibart and elebsiran to treat chronic hepatitis delta virus one month earlier than projected. The company said this includes more than 60 participants in two additional groups, with one evaluating tobevibart given...
Apple Faces Brighter Days Despite Weak iPhone Sales in China, Wedbush Says
Apple Faces Brighter Days Despite Weak iPhone Sales in China, Wedbush Says
Mar 5, 2024
12:04 PM EST, 03/05/2024 (MT Newswires) -- Apple ( AAPL ) may be navigating a stormy period in the near term amid weak iPhone sales in China, but the company is likely to see brighter days ahead, Wedbush said in a note Tuesday. Apple's ( AAPL ) decision to abandon its electric vehicle project to focus solely on artificial intelligence...
Planet 13 Holdings Prices Public Offering -- Shares Down Near 23%
Planet 13 Holdings Prices Public Offering -- Shares Down Near 23%
Mar 5, 2024
12:00 PM EST, 03/05/2024 (MT Newswires) -- Planet 13 Holdings Inc. ( PLNH ) has priced its previously announced underwritten public offering. The company will issue and sell 18.75 million units at US$0.60 each for total gross proceeds of US$11.3 million. The underwriters have also been granted a 15% over-allotment option, which, if fully exercised, will yield total gross proceeds...
--Alphabet's YouTube Investigating Loading Issues, Working on Fix
--Alphabet's YouTube Investigating Loading Issues, Working on Fix
Mar 5, 2024
12:05 PM EST, 03/05/2024 (MT Newswires) -- Price: 132.82, Change: -1.38, Percent Change: -1.03 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved